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Abstract
Background: There is currently an unprecedented expressed need and demand for estimates of
maternal mortality in developing countries. This has been stimulated in part by the creation of a
Millennium Development Goal that will be judged partly on the basis of reductions in maternal
mortality by 2015. 
Methods: Since the launch of the Safe Motherhood Initiative in 1987, new opportunities for data
capture have arisen and new methods have been developed, tested and used. This paper provides
a pragmatic overview of these methods and the optimal measurement strategies for different
developing country contexts.
Results: There are significant recent advances in the measurement of maternal mortality, yet also
room for further improvement, particularly in assessing the magnitude and direction of biases and
their implications for different data uses. Some of the innovations in measurement provide efficient
mechanisms for gathering the requisite primary data at a reasonably low cost. No method,
however, has zero costs. Investment is needed in measurement strategies for maternal mortality
suited to the needs and resources of a country, and which also strengthen the technical capacity to
generate and use credible estimates.
Conclusion: Ownership of information is necessary for it to be acted upon: what you count is what
you do. Difficulties with measurement must not be allowed to discourage efforts to reduce maternal
mortality. Countries must be encouraged and enabled to count maternal deaths and act.
Background
In 2000, 189 countries signed-up to improve maternal
health as one of the eight Millennium Development
Goals (MDGs). Progress towards this MDG-5 can be
measured using a wide variety of indicators [1]. Govern-
ment and donor commitments to maternal health can be
monitored using financial indicators and policy approv-
als. Investment in maternal health programmes can be
tracked by measuring inputs (such as midwifery training),
outputs (such as the number of midwives posted) and
processes (such as the uptake of skilled delivery care) [2].
These indicators are necessary for planning, implement-
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health. However, there is also a need to show progress in
terms of impact: reduced mortality, complications and
disabilities, and improved health. In general, however, it
is easier to track the inputs and outputs of a programme
than its impact [3].
For developing countries without routine registration and
medical certification of cause of death, measuring who
dies and the cause of death is particularly difficult, and
maternal mortality is no exception [4]. Currently, two-
thirds of countries do not have the means to fully count or
register their populations. Long-term efforts are needed to
strengthen country capacities for comprehensive routine
reporting of births and deaths. In the interim, measure-
ment scientists have devised a range of alternative
approaches that can help many countries without com-
prehensive vital statistics to generate estimates of mortal-
ity for various population sub-groups and causes. These
alternatives approaches have evolved considerably over
the last half-century [5]. Some are predominantly empiri-
cal approaches which rely on capturing new data on
deaths, and others predominantly analytical, adjusting or
modelling existing data on deaths and other related varia-
bles. Advances in the measurement of child mortality
have been more marked than for adult mortality [6],
although techniques for some cause-specific adult causes,
such as HIV/AIDS [7], have improved in the last two dec-
ades.
Maternal mortality, a subset of adult female deaths, has
also benefited from new or enhanced approaches for use
in resource-poor countries [8]. While none of these is
ideal compared with the gold standard of complete death
registration, they do enable many countries to begin to
establish the magnitude of the problem within their own
borders. This article aims to raise awareness of the alterna-
tives among all who commission and act upon informa-
tion on maternal mortality. We summarize the main
opportunities and options for generating empirical esti-
mates, describe their evolution and evaluation, and pro-
pose optimal measurement strategies for different country
contexts. It is timely to emphasize these opportunities for
a number of reasons, and not just because one of the two
indicators for MDG-5 is maternal mortality. First, to fur-
ther help empower countries to measure maternal mortal-
ity and 'own' their national estimates. Second, to
challenge the prevailing view of measurement stagnation
[9]: that maternal mortality is too difficult or too expen-
sive to measure. Third, to respond to the heightened need
for health outcome data owing to results-based financing
of maternity services in developing countries [10].
Methods
Laying-out the opportunities and options
We focus in this paper primarily on measuring the magni-
tude and trends in maternal mortality at national and
major sub-national levels; Table 1 defines the key terms
and indicators we use. We do not address approaches
whose main purpose is to identify or improve interven-
tions to prevent maternal deaths, such as quality of care
audits or confidential enquiries [11]. Similarly, we do not
discuss the various approaches and indicators which may
act as proxy measures of maternal mortality, but which
also provide essential information for monitoring pro-
grammes, such as the UN process indicators [12] and
Unmet Obstetric Need [13]; these are reviewed in several
recent papers [14-16]. Opportunities for measuring
maternal mortality, as for other mortality outcomes, can
be categorized according to cost, complexity, time
involved, desired precision of the estimates or compara-
bility over time. The intended utility of the estimates
affects the required scope and accuracy of the information
required, and the availability of resources affects the suit-
Table 1: Principal definitions and measures of maternal mortality
Pregnancy-related death is the death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the cause of death. This 
is a time-of-death definition.
Maternal death is the death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and the site of the 
pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes. This definition requires 
cause-of-death information in order to exclude incidental causes.
Maternal mortality ratio (MMR): number of maternal deaths during a given time period per 100,000 live births during the same time period.
Maternal mortality rate: number of maternal deaths in a given time period per 100,000 women of reproductive age, or woman-years of risk 
exposure, in the same time period.
Lifetime risk of maternal death: the probability of maternal death across a woman's reproductive life, usually expressed in terms of odds.
Proportion of maternal deaths among female deaths (PMDF): maternal deaths as a proportion of all female deaths of reproductive age, 
usually defined as 15–49, in a given time period.Page 2 of 8
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practical, non-specialist perspective to understanding the
alternatives. Table 2 shows the two overriding questions
that must be asked from the outset, and which lead to fur-
ther practical considerations. The final choice of options
to measure maternal mortality is often an iterative proc-
ess, which involves making trade-offs between all of the
considerations in Table 2.
So what are these opportunities and options? Figure 1
introduces the alternatives schematically, and highlights
the basic distinction between empirical approaches, the
primary focus of this paper, and analytical approaches,
which are discussed briefly later. Here we are also distin-
guishing between the primary mechanism or platform
(measurement opportunity) for gathering the data, and
the method (measurement option) used to identify
maternal deaths and derive estimates of mortality. Figure
1 proposes five major data-gathering opportunities: (1)
death registration; (2) health facilities; (3) decennial cen-
suses; (4) surveys; and (5) surveillance. In addition, there
are composite approaches which draw upon various com-
binations of these five to identify all deaths of women of
reproductive age and then ascertain the maternal cases
and circumstances. These are referred to collectively as
Reproductive Age Mortality Studies (RAMOS) [17,18].
The five primary opportunities can be broadly grouped
into routine or special sources. Generally speaking, rou-
tine opportunities yield a narrower range of information
about maternal deaths than special studies but, with the
exception of censuses, are continuously available and able
to provide data for small geographical units. Moreover, as
they form part of the wider information system, their use
to measure maternal mortality involves minimal extra
costs. The drawbacks, however, relate primarily to availa-
bility, reliability, completeness and coverage. Special
studies, on the other hand, require more of the resources
flagged in Table 2, but have the potential to produce
detailed additional information on the circumstances of
deaths. Their drawbacks relate primarily to margins of
uncertainty due to both sampling and non-sampling
errors, timeliness and predictability.
Figure 1 also shows that for some data-capture opportuni-
ties, such as surveys, there are a number of alternative
methods or options that can be used within them to iden-
tify maternal deaths. For example, surveys provide an
opportunity to apply methods which seek deaths reported
in the household or among sisters, or deaths reported
through respondents using sampling at service sites (SSS)
[19], such as antenatal care. Additional file 1 acts as a ref-
erence resource, providing details on the characteristics of
each option for measuring maternal mortality, as well as
their strengths and limitations, and further supporting ref-
erences [20]. There are also a number of web-based
resources which provide additional details on specific
options, now including a site dedicated to maternal mor-
tality measurement [21].
Two other useful differences between opportunities for
data capture are, firstly, whether deaths are identified
actively or passively and, secondly, whether the starting
point is all deaths, reproductive-aged female deaths, preg-
nancy-related deaths or maternal deaths (see Table 1 for
definitions). Active identification enumerates cases in the
population through direct interviews in the context of a
census, survey or surveillance. Passive approaches, such as
civil registration or health facility statistics, rely on deaths
already captured by an existing system but go on to extract
the maternal or pregnancy-related fraction. As a compos-
ite approach, RAMOS involves both active and passive
identification of deaths. The distinction between active
and passive is important in terms of completeness of
reporting, with the latter more prone to omission of
deaths and to bias because certain population subgroups
are underrepresented.
The techniques for differentiating maternal from non-
maternal deaths fall broadly into those with involvement
from health professionals (medical certification or health
facility data) versus those based on lay reports. With the
Table 2: Two key issues to clarify prior to measuring maternal mortality
Why is the estimate needed?
• To generate a broad estimate of the magnitude of the problem
• To identify detailed causes, differentials and determinants
• To identify differences in levels within a country
• To permit cross-country comparisons
• To enable regular monitoring of progress
What resources are available?
• Existing data sources or data-collection opportunities, for example routine civil registration, large multi-purpose surveys
• Human resources, for example technical skills to design a survey, or to manage, analyse and interpret data
• Field budget, for example funds available for new data collection
• Time available, for example estimate needed immediately, in 1–2 years time, or longerPage 3 of 8
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between the presence or absence of diagnostic procedures,
such as post-mortem, operative or laboratory results. With
lay reports, maternal deaths are identified through time-
of-death questions (yielding pregnancy-related mortality)
or a verbal autopsy. The latter is a structured interview
and/or narrative account administered to caregivers or
family members of the deceased to identify signs and
symptoms and thus determine probable cause(s) of
death.
Alongside empirical measurement, there are three main
analytical approaches which have been developed specif-
ically for maternal mortality (Figure 1). Birth and Death
Record Linkage identifies maternal deaths by using exist-
ing records of births (including stillbirths if available) and
deaths obtained from routine civil registration or demo-
graphic surveillance. Records of births and reproductive-
age female deaths are compared, and those which can be
linked are deemed to be pregnancy-related deaths. Cap-
ture-recapture [22] or Dual (records) Methods use statisti-
cal methods to correct for underreporting from two
sources of maternal deaths [23]. Finally, statistical models
have been used to estimate levels of maternal mortality for
countries without any reliable national-level empirical
data. United Nations' [24] models use statistical regres-
sion and the proportion of maternal deaths among deaths
of women of reproductive age to derive estimates of
maternal mortality.
Evolution and evaluation of opportunities and options
The five main empirical opportunities and related options
for measuring maternal mortality (Figure 1) have evolved
over last 20 years in response to the demand generated
initially by the Safe Motherhood Initiative and sustained
by the advent of MDG-5. In developing countries, height-
ened interest in data on maternal mortality began in the
mid-1980s with a series of special studies, as discussed in
a report by the WHO [25]. These revealed the serious
underreporting in routine statistics and gave early insights
into the challenges of capturing maternal deaths, particu-
larly where the vast majority occurs without contact with
Opportunities and options for measuring maternal mortalityFigure 1
Opportunities and options for measuring maternal mortality. Colour key: Orange = longitudinal & continuous cap-
ture of deaths; Pink = cross-sectional capture; Green = mixed approach; Blue = no new capture of deaths. * Deaths actively 
sought by measurement option ** Deaths passively recorded, as dependent on relatives or health providers to notify death.
Analytical 
Dual method 
or capture –
recapture: 
corrects for 
under -
reporting
1.Death 
Registration
Options:
1.a Civil 
Registration**
1.b Sample Vital 
Registration*/**
1.c Sample Vital 
Registration, with 
Verbal Autopsy 
(SAVVY)*
Routine Opportunities
2. Health 
Facility 
Statistics**
Empirical measurement
3. Decennial 
Census*
Special Opportunities
4. Surveys*
Options:
4.a Population-based 
survey, asking about 
deaths in household
4.b Population-based 
survey, with  Indirect 
Sisterhood – asking about 
deaths of sisters, without 
dates
4.c Population-based 
survey , with Direct 
Sisterhood – asking about 
deaths of sisters, with 
dates
4.d Sampling at Service 
Sites (SSS) – using direct 
sisterhood method
Composite approaches – Reproductive Age Mortality Studies: In-depth review of reproductive-age female 
deaths identified from routine &/or special opportunities, & follow-up investigation of maternal deaths
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Options:
5.a Demographic 
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5.b Active surveillance of 
reproductive age female 
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maternal 
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ence has accumulated on these challenges and the pub-
lished literature has been very explicit about them
[26,27]; some would argue overly so [9]. The principal
challenges are two-fold: first, to obtain sufficient or relia-
ble detail, in official records or relatives' reports, to differ-
entiate maternal from non-maternal causes; and, second,
due to the comparative rarity of the event on a population
basis, extremely large samples or complete enumeration
are required to produce stable estimates. However, whilst
facing similar difficulties to all-cause and cause-specific
adult mortality, the maternal sub-group also has some
positive features which make ascertainment easier and
likely to be more complete. In most settings, pregnancy is
a memorable event, and death related to pregnancy
among otherwise healthy young women even more so.
These deaths also cluster around the time of labour and
delivery and in the following 24 hours, in other words at
a time when the woman's pregnancy status is well recalled
by reporting relatives [28].
Paying increased attention to the challenges of measuring
maternal mortality has yielded benefits, both to the issue
of maternal death itself and to the methods and empirical
data available. For example, since national estimates for
maternal mortality were first released in 1996 by WHO
and UNICEF [24], the proportion of countries lacking
usable data, and so dependent on modelled figures, has
declined from almost half in 1990 to just over one-third
in 2005 [29]. This growth in alternative measurement
opportunities and options highlights the important con-
tribution made by the Demographic and Health Surveys
as a major platform for applying the Direct Sisterhood
Method [30].
The different options for estimating maternal mortality
detailed in Additional file 1 have different strengths and
weaknesses. There is unfortunately no standard metric for
valuing the advantages and disadvantages of measure-
ment options. Rather comparisons need to be made based
on broad categories and propensities for certain qualities.
These are also summarized in Additional file 1. Inevitably,
there are trade-offs to be made, for example between prac-
tical considerations, such as cost, time and statistical
capacity, and scientific criteria of precision, reliability,
comparability and validity. Many of the resource issues
stem from the large sample sizes or complete enumera-
tion needed, mentioned earlier, and this places practical
and scientific considerations in direct competition. More-
over, the decision about size is not solely a statistical mat-
ter, but also influenced by the purpose of the resulting
estimates, and hence the degree of certainty needed. There
have been few publications on the comparative costs and
benefits of different measurement opportunities and
options. Generally speaking, routine and continuous sys-
tems, such as civil registration or demographic surveil-
lance, are more cost-effective than special studies but
require long-term commitment and attention to quality.
Censuses are major undertakings, both in terms of human
and financial resources, but the marginal cost of adding
questions on maternal mortality is small [31].
From a scientific perspective, the validity and reliability of
measurement options are of primary concern. There is,
however, a conundrum with evaluating any new method
for maternal mortality for use in low-income countries:
the lack of existing estimates from a gold-standard source,
namely, complete and accurate death registration. As a
consequence, many so-called validation studies are,
strictly speaking, comparative assessments of two or more
alternatives, ideally applied to the same geographical area,
population and time period. For example, recent work in
Bangladesh compared pregnancy-related deaths in the
household with deaths among sisters, and found
extremely similar estimates of maternal mortality but with
wide confidence intervals [8].
There are very few comprehensive appraisals of the mag-
nitude of bias and uncertainty for the main opportunities
and options for measuring maternal mortality. This gap
needs to be addressed as a research and development pri-
ority, linking-up with similar efforts for other outcomes.
One appraisal, of the Direct Sisterhood Method used by
the DHS [32], found relative errors in the maternal mor-
tality estimates averaging at 15% across 14 countries.
Another form of appraisal has been published for the cen-
sus as a means of measuring maternal mortality [31].
Although there are no sampling errors in such complete
enumerations, non-sampling errors resulted in the need
to upwardly adjust the numbers of adult female deaths,
maternal deaths and, indeed, births in all but one of the
five countries included in the assessment. In terms of
health facility statistics, these will always be biased where
some maternal deaths still occur in the community, but
the direction of the error in estimates is hard to assess and
quantify. For example, where facilities have a dispropor-
tionate fraction of high-risk deliveries, then the estimate
may be much higher than that for the population as a
whole and, conversely, where many deaths do not reach
care, the facility figure will be an underestimate of the true
population level. Moreover, this bias is often further
aggravated by the omission of maternal deaths occurring
on non-obstetric wards.
All opportunities and options for measuring maternal
mortality in fact face the same two sources of error: iden-
tifying adult female deaths and/or determining whether
such deaths are maternal or pregnancy-related. There are
several demographic techniques (see Additional file 1) for
assessing and adjusting identification of adult femalePage 5 of 8
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veys. Distinguishing whether deaths are pregnancy-related
on the basis of time of death is widely regarded as valid in
comparison with medical certification of death [33],
although differentiating specific sub-causes of maternal
death is more problematic. The recently developed stand-
ardized verbal autopsy tool developed by WHO repre-
sents a significant advance but will itself require
validation [34]. Recent work with a computer-based algo-
rithm [35] for assigning deaths from verbal autopsies
which was applied in Burkina Faso showed that the Direct
Sisterhood Method questions on time-of-death relative to
pregnancy status differed by less than 10% from symp-
tom-based questions in detecting pregnancy-related
deaths.
Country strategies for measuring maternal mortality
In this final section of the paper, we turn to the need for
measurement strategies to generate estimates of levels and
trends in maternal mortality, suited to specific contexts or
developmental phases of a country. Additional file 2 pro-
poses four phases in the evolution of measurement strate-
gies, and provides examples of countries currently at these
different stages. The phases are defined primarily on the
basis of the status of the civil registration system and cause
of death ascertainment, with complete and accurate cov-
erage regarded as the optimum in the fourth and final
phase. Even at this state of development, it is still relevant
for other complementary measurement opportunities and
options to be used, since no single approach can ade-
quately meet all of the needs for information on maternal
mortality.
As can be seen from Additional file 2, there is considerable
overlap in strategies between phases. We emphasize the
importance of taking advantage of add-on opportunities
provided via the decennial census and large multi-pur-
pose surveys, since the incremental costs of obtaining data
on maternal mortality from these sources is marginal.
However, these are not very timely, usually every decade
for the census and every 4–5 years for large multi-purpose
surveys, and often delayed in their implementation as
well as the analysis and release of findings. For the four
given states of the civil registration system in Additional
file 2, other measurement opportunities are proposed on
the basis of the likely resources available and the com-
pleteness and accuracy of health facility statistics. A prac-
tical guide on how to select between the different options
for measuring maternal mortality shown earlier in Addi-
tional file 1 and for the specific phases indicated in Addi-
tional file 2 is now available as a web-based resource [21].
There are two further key requirements in developing
countries for any measurement strategy to yield the relia-
ble, timely and comparable data on maternal mortality
required by decision-makers. First, the data must be proc-
essed, analysed, interpreted and communicated. This
analysis should include estimation of uncertainty sur-
rounding the maternal mortality indicators, as well as the
use of various adjustment techniques to correct for under-
or over-reporting of deaths or births. More developmental
work is needed to refine some of these techniques, and to
help reconcile and understand variation in estimates from
different sources. Secondly, all measurement strategies
depend on the skills and capacity of personnel in-country
to undertake competently all stages from design through
to communication, sometimes with external technical
support. There is an urgent need to strengthen this skills
base for all aspects of health information systems in devel-
oping countries [36].
Conclusion
There is currently an unprecedented expressed need and
demand for estimates of maternal mortality in developing
countries. This has been stimulated in part by the creation
of an MDG that will be judged partly on the basis of
reductions in maternal mortality by 2015. The proposed
shift towards results-based financing of maternal, neona-
tal and child health programmes by donors is now adding
further incentives to improve data on this and other out-
come indicators [37]. There are significant challenges to
meeting these needs and demands which we would be
foolish to ignore. Many of these are, however, very similar
to the issues faced and, to a degree, overcome by other
specific health problems, such as HIV/AIDS. The limita-
tions of civil registration and routine health information
systems in many countries are serious, but only by making
maximum use of those data which are adequate and by
investing in a continuous process of improvement will
these be realized as the optimal sources [36]. Universal
counting of maternal deaths should be the goal [38]. This
aspiration does not, however, mean an indefinite wait for
high-quality data on maternal mortality.
Since the launch of the Safe Motherhood Initiative in
1987, new opportunities for data capture have arisen and
new methods have been developed, tested and used. No
approach, however, can be perfect, and there is certainly
still much room for improvement, especially assessing the
magnitude and direction of biases and their implications
for different data uses. Some of the innovations in meas-
uring maternal mortality provide efficient mechanisms
for gathering the requisite primary data at a reasonably
low cost. No method, however, has zero costs. Investment
is needed in measurement strategies for maternal mortal-
ity suited to the needs and resources of a country, and
which also strengthen technical capacity to generate and
use credible estimates. Ownership of information is nec-
essary for it to be acted upon: what you count is what you do
[39]. Difficulties with measurement must not be allowedPage 6 of 8
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tries must be encouraged and enabled to count maternal
deaths and act.
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